BRPF3
| Official symbol: | BRPF3 |
| Full name: | bromodomain and PHD finger containing 3 |
| Location: | 6p21.31 |
| Also known as: | KIAA1286 |
| Entrez ID: | 27154 |
| Ensembl ID: | ENSG00000096070 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 5 |
|
|
| Fusions detected in 5 cancer type(s) |
|
| |
|
|
|
| Functional class: | Epigenetic |
| JensenLab PubMed score: | 2.70 (Percentile rank: 19.58%) |
| PubTator score: | 0.44 (Percentile rank: 5.97%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
